Frontlight ResearchEarly access
Liver cirrhosis trials in Singapore
4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Singapore
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Singapore
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - No phaseTaking peoplePredictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
- Where
- Singapore
- Age
- 18 years and over
- People
- 2,200
- Run by
- Singapore General Hospital
See details and how to joinNCT07438288 - No phaseNot yet taking people in SingaporeSafety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
- Where
- Singapore
- Age
- 18 years and over
- People
- 375 worldwide
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06549673